A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
33 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 12+
Code: NCT06338995·Phase 3·Recruiting